|

Xanomeline Enteric Capsule Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: BMS-986519, KarX-EC

Pipeline

Phase 3: 2

Top Sponsors

  • Bristol-Myers Squibb2

Indications

  • Alzheimer's Disease2
  • Alzheimer Disease2

Chandler, Arizona1 trial

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

Chandler Clinical Trials, LLC

Phase 3

Scottsdale, Arizona1 trial

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Imaging Endpoints

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.